Home » Biogen CEO Tries to Refill Early-Stage Drug Pipeline He Decimated
Biogen CEO Tries to Refill Early-Stage Drug Pipeline He Decimated
Biogen Idec CEO George Scangos is trying to solve a problem of his own creation: He must replenish an early-stage drug research pipeline that he decimated after taking over the biotechnology company in 2010.
The Wall Street Journal
The Wall Street Journal
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May